Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Competing interests: None declared. 6. Front Endocrinol (Lausanne). 2022 Dec 14;13:1052592. doi: 10.3389/fendo.2022.1052592. eCollection 2022. A narrative review of diabetic bone disease: Characteristics, pathogenesis, and treatment. Wu B(1), Fu Z(1), Wang X(1), Zhou P(1), Yang Q(1), Jiang Y(1), Zhu D(1). Author information: (1)Department of Orthopaedic Trauma, Center of Orthopaedics and Traumatology, The First Hospital of Jilin University, Changchun, China. Comment in Front Endocrinol (Lausanne). 2023 May 24;14:1194241. doi: 10.3389/fendo.2023.1194241. Recently, the increasing prevalence of diabetes mellitus has made it a major chronic illness which poses a substantial threat to human health. The prevalence of osteoporosis among patients with diabetes mellitus has grown considerably. Diabetic bone disease is a secondary osteoporosis induced by diabetes mellitus. Patients with diabetic bone disease exhibit variable degrees of bone loss, low bone mineral density, bone microarchitecture degradation, and increased bone fragility with continued diabetes mellitus, increasing their risk of fracture and impairing their ability to heal after fractures. At present, there is extensive research interest in diabetic bone disease and many significant outcomes have been reported. However, there are no comprehensive review is reported. This review elaborates on diabetic bone disease in the aspects of characteristics, pathogenesis, and treatment. Copyright © 2022 Wu, Fu, Wang, Zhou, Yang, Jiang and Zhu. DOI: 10.3389/fendo.2022.1052592 PMCID: PMC9794857